Occudo Quantitative Strategies LP Mirati Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

  • $549 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$39.16 - $88.71 $135,728 - $307,468
-3,466 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$75.82 - $150.97 $262,792 - $523,262
3,466 New
3,466 $285,000
Q1 2021

May 14, 2021
SELL
$158.92 - $221.61 $1.17 Million - $1.64 Million
-7,393 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$162.05 - $240.27 $1.2 Million - $1.78 Million
7,393 New
7,393 $1.62 Million

Others Institutions Holding MRTX

# of Institutions
19
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email